FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1195711000001102: Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22676901000001115 Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22677001000001116 Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Is pack of Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Has active ingredient Propranolol hydrochloride false Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Has VMP Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Has specific active ingredient Propranolol hydrochloride true Inferred relationship Existential restriction modifier
Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Inderetic 80mg/2.5mg capsules (AstraZeneca) 60 capsule Is a True Propranolol 80mg / Bendroflumethiazide 2.5mg capsules 60 capsule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start